These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2657282)

  • 21. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
    Asaki S; Sato A; Sakurada H; Takeda T; Hongo M; Toyota T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S56-8. PubMed ID: 7594342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New findings in the etiopathogenesis of ulcers and reevaluation of therapy].
    Rotkvić I; Troskot B; Duvnjak M; Supanc V
    Lijec Vjesn; 1991; 113(5-6):150-3. PubMed ID: 1961077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug therapy for peptic ulcer: drugs that act on the gastric mucosa.
    Kauffman GL
    J Clin Gastroenterol; 1981; 3(Suppl 2):95-101. PubMed ID: 6119340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
    Annibale B; D'Ambra G; Luzzi I; Marcheggiano A; Iannoni C; Paoletti M; Anania MC; Marignani M; Delle Fave G
    Am J Gastroenterol; 1997 May; 92(5):790-4. PubMed ID: 9149186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori-negative peptic ulcers: frequency and implications for management.
    Freston JW
    J Gastroenterol; 2000; 35 Suppl 12():29-32. PubMed ID: 10779214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gastroduodenal ulcer--changes in surgical therapy by long-term drug treatment].
    Peitsch W
    Zentralbl Chir; 1986; 111(23):1433-40. PubMed ID: 2881413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The drug prophylaxis of peptic ulcer exacerbations].
    Grigor'ev PIa; Iakovenko EP; Agafonova NA; Prianishnikova AS; Soluianova IP; Iakovenko AV; Vasil'ev IV; Agrba VZ; Stepanov AV; Kolodkin AM
    Ter Arkh; 1995; 67(2):26-9. PubMed ID: 7725253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
    Hsu CC; Lu SN; Changchien CS
    Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agents with tricyclic structures for treating peptic ulcer disease.
    Berardi RR; Caplan NB
    Clin Pharm; 1983; 2(5):425-31. PubMed ID: 6354568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.